The UK plans to test US firm Eli Lilly's weight-loss jab Mounjaro to help the burden on the national health care system. Over a quarter of UK adults suffered from obesity in 2023, according to government data.

Britain is set to explore the potential of Eli Lilly's weight loss drug to improve public health and economic productivity by reducing long-term sickness. Health minister Wes Streeting believes this initiative, supported by substantial investment and research, could significantly impact obesity management and alleviate NHS demands.

The health secretary announces trials to explore the effect of weight loss drugs on worklessness.

The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will study the impact of a weight-loss drug on work and productivity.

Obese unemployed people will be given weight-loss injections to help them get back into work, the Health Secretary has said.

Health Secretary Wes Streeting said ''iIllness caused by obesity causes people to take an extra four sick days a year on average"

U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.